FDA Issues Guidance to Increase Clinical Trial Racial, Ethnic Diversity

The FDA has issued a new guidance to increase the racial and ethnic diversity in the clinical trials for all medical products.

Related Keywords

,Office Of Minority Health ,Oncology Center ,Radiological Health ,Drug Administration ,Biden Administration ,Health Equity ,Diversity In Clinical Trials Initiative ,Improve Enrollment ,Underrepresented Racial ,Ethnic Subgroups ,Clinical Trials ,Ethnicity Diversity Plan ,Minority Health ,Clinical Trials Initiative ,Cancer Moonshot ,White House Cancer Cabinet ,Project Equity ,Drug Evaluation ,Biologics Evaluation ,